FISH analysis for MYC, BCL2, and BCL6 alterations was performed on tissue microarrays for 200 patients with PT-DLBCL, using break-apart probes and the same methods for our systemic DLBCL samples, as described previously (17). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.